Drug profile · INN
dexmethylphenidate hydrochloride
DEXMETHYLPHENIDATE HYDROCHLORIDE
dexmethylphenidate hydrochloride (DEXMETHYLPHENIDATE HYDROCHLORIDE) is a norepinephrine transporter inhibitor. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Drug details — dexmethylphenidate hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.89
Quick answer
dexmethylphenidate hydrochloride (DEXMETHYLPHENIDATE HYDROCHLORIDE) is a norepinephrine transporter inhibitor. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Norepinephrine transporter inhibitor
Primary target: Sodium-dependent dopamine transporter
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is dexmethylphenidate hydrochloride?
dexmethylphenidate hydrochloride (DEXMETHYLPHENIDATE HYDROCHLORIDE) is a norepinephrine transporter inhibitor. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for dexmethylphenidate hydrochloride?
DEXMETHYLPHENIDATE HYDROCHLORIDE is a marketed brand name for dexmethylphenidate hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of dexmethylphenidate hydrochloride?
dexmethylphenidate hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.